Sentences with phrase «treatment of hypertension»

About Blog Medical education site for health professionals in the field of kidney disease, especially dialysis, treatment of hypertension, and clinical nephrology.

Under - diagnosis and under - treatment of hypertension is a major, seemingly intractable problem in all health - care systems.

The treatment of hypertension involves lifestyle changes, including weight loss, dietary modifications, smoking cessation, alcohol reduction, exercise, and stress management.

Humans have several medications available for the treatment of hypertension, but there are no drugs currently approved for the specific treatment of hypertension in cats.

Identification and treatment of hypertension in cats helps avoid serious consequences, such as loss of vision or stroke - like events.

Furthermore, these findings suggest that partially replacing carbohydrate with soy or milk protein might be an important component of nutrition intervention strategies for the prevention and treatment of hypertension.

Genetic variation influencing blood pressure has the potential to identify new pharmacological targets for the treatment of hypertension.

Such shortfalls in bringing clinical care in line with scientific evidence, all three authors agree, are likely to extend to other prevention issues beyond the treatment of hypertension.

The results support current clinical guidelines on the treatment of hypertension in younger patients with CKD, but a more cautious blood pressure - lowering strategy for very elderly patients with CKD may be reasonable.

For example, the treatment of hypertension went through several significant changes from the days of the a-adrenoceptor antagonists to that of the latest generation of angiotensin - converting enzyme inhibitors and angiotensin II receptor blockers.

Not exact matches

In addition to Trevyent, SteadyMed's portfolio includes a two day, single use, disposable PatchPump technology with treprostinil, a vasodilatory prostacyclin analogue, for the subcutaneous treatment of pulmonary arterial hypertension (PAH).

United Therapeutics will pay $ 4.46 per share in cash at closing yesterday and an additional $ 2.63 per share in cash upon the achievement of a milestone related to the commercialization of SteadyMed's leading drug candidate Trevyent for the treatment of Pulmonary Arterial Hypertension (PAH).

Potential subjects were accepted into the study if they had none of the following conditions: severe or symptomatic cardiac disease or hypertension; history of bleeding disorders; chronic history of gastric, intestinal, liver, pancreatic, or renal disease; any portion of the stomach or the intestine removed (other than an appendectomy); history of intestinal obstruction, malabsorption, or use of antacid drugs; cancer (active or use of medications for a history of cancer treatment within the past 5 y); history of chronic alcoholism; a convulsive disorder; or abnormal results in screening blood or urine samples.

Grant N. Pierce, PhD, Executive Director of Research at St Boniface Hospital in Canada, discusses an alternative or complementary treatment to medication for hypertension.

The treatment of gestational hypertension follows a different set of guidelines than the treatment of general high blood pressure outside of pregnancy.

There is «moderate quality» evidence that treatment reduces the chance of hypertension (NNT 18.1) and pre-eclampsia (NNT 21).

Detection, treatment, and control of hypertension in adulthood does not reduce cardiovascular disease risk to normotensive levels (9), supporting efforts to identify primary prevention interventions that could be started in early life.

One way out of this dilemma, Daviglus notes, is to design a study in which patients suffering from hypertension get treatment, and doctors analyze the results based on how well the patients» blood pressure was controlled.

Like Gilead, which aims to develop treatments for HIV / AIDS, hepatitis B and C, influenza, pulmonary arterial hypertension, and cystic fibrosis, other top employers accentuate the positive aspects of the life science industry by performing their R&D in entirely new areas.

The results show that while the prevalence of hypertension in the Hispanic community is nearly equal to that of non-Hispanic whites, diagnosis of the disease is much lower, as is general awareness of its symptoms and treatment options.

«Given the relative ease of identifying hypertension and the availability of low cost medications, enabling better access to diagnostic and treatment services should be prioritized to reduce the burden of cardiovascular disease on Hispanic populations.

The study, «Prevalence of hypertension, awareness, treatment and control in the Hispanic Community,» led by Dr. Paul D. Sorlie of the National Heart, Lung, and Blood Institute (NHLBI), sampled 16,400 individuals, making it one of the largest and most rigorous health studies of the Hispanic community.

In the case of chronic diseases like hypertension, patients not sticking to their treatment plans is one of the main causes of treatment failure.

It is possible that medical advances over the past few decades in the treatment of type 2 diabetes, hypertension and high cholesterol levels have had a greater impact on people who are overweight — which increases the risk for these conditions — whereas the effect was much smaller in those of normal weight.

Our aim was to find out whether pregnancies from egg donation are genuinely associated with a higher risk of hypertension and pre-eclampsia than those from treatments using the patient's own eggs.

The study, which is published today in the Journal of Clinical Hypertension and is supported by Barts Charity, devised a novel treatment strategy for 55 patients, involving fractional dosing with tablets (halving or quartering pills), liquid formulations of antihypertensive drugs and patch formulations of antihypertensive drugs — plus use of unlicensed drugs that lower blood pressure.

«Increases in hospitalizations may reflect both improved recognition of pulmonary hypertension as well as an increase in treatment options.»

«This study illustrates the importance of recognizing and diagnosing pulmonary hypertension so patients can receive proper treatment,» says Richard S. Irwin, MD, Master FCCP, and editor in chief, CHEST.

Jerry Yee, M.D., division head of Nephrology and Hypertension at Henry Ford and the study's senior author, says the findings suggest the antibiotic therapy is a potential game - changer for hemodialysis treatment.

The Pulmonary Hypertension Association has designated this day as part of its efforts to increase awareness of this type of pulmonary hypertension, the methods for diagnosis and the available treatmHypertension Association has designated this day as part of its efforts to increase awareness of this type of pulmonary hypertension, the methods for diagnosis and the available treatmhypertension, the methods for diagnosis and the available treatment options.

India achieved the highest rate of treatment effectiveness (55 per cent); the lowest rate of condition control was in Ghana (four per cent); the lowest treatment effectiveness was in Russia (17 per cent), which had the second highest rate of hypertension (71 per cent).

Limited awareness and ineffective treatment meant that only eight per cent of people with hypertension had their condition under control, compared to a rate of 14 per cent in India, the highest of the six countries studied.

«Because PGAs are a first line of treatment for glaucoma, these results provide physicians with one reason to reconsider when they should be added in new patients, particularly those where the aim is to prevent glaucoma such as in ocular hypertension patients or glaucoma suspects,» Dr. Pasquale said.

Most importantly, these studies show that treatment with vitamin D3 can significantly restore the damage to the cardiovascular system caused by several diseases, including hypertension, atherosclerosis, and diabetes, while also reducing the risk of heart attack.

They say the rates of hypertension in low and middle - income countries are striking and that levels of treatment and control are inadequate, despite half those sampled being aware of their condition.

«We know that obesity is a problem, but we need to be as serious about the management, prevention and treatment of the obesity crisis as we are about conditions like hypertension and diabetes.»

Those who took part in the SAGE survey were categorized as hypertensive if the mean of two measurements was equal or greater than 140mmHg (systolic blood pressure) or 90mmHg (diastolic blood pressure), or if they were taking treatment for hypertension.

Young adults, particularly men, lag behind middle - aged and older adults in awareness and treatment of high blood pressure, putting this population at an increased risk for heart attack and stroke, according to new research in the American Heart Association's journal Hypertension.

And there is the question of possible treatments, given the array of medical conditions including cardiovascular problems and hypertension associated with peripheral nervous system dysfunction in individuals with Down syndrome.

The researchers add that greater awareness of the metabolic syndrome and its health consequences may have contributed to improvements in optimizing treatment of risk factors such as hypertension and diabetes.

But anti-inflammatory treatments do not halt the progress of the disease and may cause side effects ranging from ulcers, kidney disorders, hypertension and heart disease to mental disorders and sometimes death.

This pivotal trial is the largest study conducted of renal artery denervation as a treatment for resistant hypertension and the most rigorously designed, including blinding and a sham treatment in the control arm.

«This study shows that renal denervation may be an alternative treatment for uncontrolled hypertension,» said Michael Böhm, M.D., Ph.D., University of Saarland in Homburg, Germany, and lead investigator of the study.

Up to 15 % of patients suffer from resistant hypertension (rHTN) and are unable to reduce BP below 140/90 mmHg despite adhering to full doses of an appropriate three drug treatment regimen including diuretics.»

«In reviewing this patient's case, I think we might have found a novel strategy of using pre-emptive steroids and sirolimus to mitigate organ rejection in transplant patients receiving cancer treatment involving PD - 1 inhibitors,» said Dr. Jhaveri, associate chief of the Division of Kidney Diseases and Hypertension in Northwell Health's Department of Internal Medicine.

This recommendation was based on the ability of screening to identify persons with diabetes and evidence that more - intensive blood pressure treatment was associated with reduced risk for cardiovascular events, including cardiovascular mortality, in patients with diabetes and hypertension.

The team tested AC1903 in a rat model of kidney disease caused by hypertension and saw the same results: The treatment preserved kidney podocytes and prevented the organs from failing, even in advanced disease.

Around half of all prescribed drugs act on these receptors, with GPCRs helping in the treatment of widespread diseases such as hypertension, asthma and Parkinson's disease.

WHO estimates that 80 % of cardiovascular deaths occur in low - and middle - income countries; in many of them, hypertension patients can't afford treatment, so prevention is paramount.

«The early diagnosis and treatment with well - monitored, continuous use of CPAP therapy in otherwise healthy young adults with moderate to severe obstructive sleep apnea might prevent the future development of hypertension and reduce the risk of cardiovascular complications associated with the disease,» said Korcarz.